display

Due to the situation in the intensive care units, the virologist Christian Drosten expects that further measures will be necessary in addition to the planned nationwide Corona emergency brake.

"I think that you have to react differently based on the situation now setting in the hospitals," said the corona expert from the Berlin Charité on Tuesday in the podcast "Coronavirus Update" at NDR-Info.

This must certainly happen "very soon".

"I do not expect that the situation in intensive care can be controlled with it," said Drosten, referring to the decision.

The federal cabinet decided on Tuesday to amend the Infection Protection Act.

As a result, people in large parts of Germany have to adjust to exit restrictions and closed shops according to binding nationwide guidelines.

Next week, the changes will first be decided by parliament and then passed by the Bundesrat - despite clear criticism from some countries and the opposition in the Bundestag.

display

About the limited informative value of the corona reporting numbers after Easter, Drosten said: "We will probably have to wait until the end of this week to see realistic figures again." He feared that we would then end up in a range between 20,000 and 30,000 new infections reported daily .

However, the virologist initially sees a “sustainable deceleration effect” for the schools as a result of the Easter break, as he said.

Drosten further reminded that one should not be misled after a negative rapid test result.

“It is not all as simple as it is sometimes processed argumentatively in politics.

According to the motto: Now everything can open because we now have rapid tests. "

display

Buy antigen self-tests online now

Take a nasal swab, read the result on the test strip within 15 minutes and find out whether you have Covid-19.

Order 1 piece from Amazon Order 5 pieces from Galeria Kaufhof Order 20 pieces from REWE Order 25 pieces from APONEO

Gap in the detection of infections in rapid tests

In practice, experts found that there was a gap in these tests in the detection of infections in the early phase, said Drosten.

Studies on this were still lacking.

However, it is observed that the tests only work on most of the contagious days: When testing directly at the onset of symptoms, however, the test can still be negative.

In comparison, a laboratory test (PCR) could indicate an infection several days in advance.

display

Nevertheless, Drosten considers the use of rapid tests for people with symptoms and their regular use, for example in school classes and at work, to be justified and sensible.

A fresh infection can then be overlooked in individual cases - but it is noticed a few days later.

"There is only one thing that is a bit dangerous," he said: the idea of ​​not being contagious when doing the test at the cash register at an event hall or at the porter's lodge at a government building.

Infected people could then slip through and infect other people.

On Wednesday, Drosten underlined the importance of testing stable social groups on Twitter.

Despite the risk of risk, it is better than not to test at all.

display

About new studies on variant B.1.1.7 discovered in Great Britain, in which, contrary to earlier data, no evidence of a higher lethality of the variant is seen, Drosten said that this did not completely change the picture for him.

Based on its sample, one of the studies can only make statements about cases that were treated with Covid-19 in hospital.

Drosten concluded that he would leave the previous studies at the level of the entire population.

Drosten described the picky behavior of over 60-year-olds in federal states where you can choose the corona vaccine as a "very bad development".

Some of these elderly people now did not want to be vaccinated with AstraZeneca and preferred to wait until they could get the preparation from Biontech / Pfizer.

“You really have to say that in June you will take away the vaccination of a younger person.

And that's really not okay, "said the virologist.

“I don't think it's good when older people are picky about this.” The Standing Vaccination Commission (Stiko) now recommends AstraZeneca for people over 60. The background is rare cases of blood clots in the cerebral veins of younger people.